Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy

Published:2016-09-13 Issue:9 Volume:11 Page:e0161938
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ropars Juliette^ORCID,Lempereur Mathieu,Vuillerot Carole,Tiffreau Vincent,Peudenier Sylviane,Cuisset Jean-Marie,Pereon Yann,Leboeuf Fabien,Delporte Ludovic,Delpierre Yannick,Gross Raphaël,Brochard Sylvain

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Population frequencies of inherited neuromuscular diseases—a world survey;AE Emery;Neuromuscul Disord,1991

2. Profiles of neuromuscular diseases. Duchenne muscular dystrophy;CM McDonald;Am J Phys Med Rehabil,1995

3. Early signs of gait deviation in Duchenne muscular dystrophy;L Doglio;Eur J Phys Rehabil Med,2011

4. Glucocorticoid corticosteroids for Duchenne muscular dystrophy;AY Manzur;Cochrane Database Syst Rev,2008

5. The pathomechanics of gait in Duchenne muscular dystrophy;DH Sutherland;Dev Med Child Neurol,1981

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of cycling training on balance and gait in children with Duchenne muscular dystrophy: A randomized controlled study;European Journal of Paediatric Neurology;2024-09

2. Ankle-foot orthosis in patients with Duchenne muscular dystrophy: a retrospective study;Fisioterapia em Movimento;2024

3. Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic–Intraosseous Administration;Archivum Immunologiae et Therapiae Experimentalis;2023-11-24

4. Development of a new instrument to evaluate gait characteristics of individuals with Duchenne Muscular Dystrophy: Gait Assessment Scale for Duchenne Muscular Dystrophy, and its validity and reliability;Early Human Development;2023-10

5. Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration;Stem Cell Reviews and Reports;2023-09-14